6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: February 25, 2020
Period of Report: February 25, 2020
Accession Number: 0001157523-20-000260

View Document ↗ View on SEC.gov ↗